FLUOGUIDE A/S

FLUO
Delayed Nasdaq Stockholm - 10:51 2022-12-02 am EST
42.95 SEK +2.26%

Turn to zoom
Prev.42.95000000
Open42.00000000
High43.50000000
Low42.00000000
Volume11 176
Latest news
11/24
11/24
11/24
11/21
Chart FLUOGUIDE A/S
Financials
Sales 2022 - - -
Net income 2022 -34,0 M -4,80 M -4,80 M
Net cash 2022 21,0 M 2,96 M 2,96 M
P/E ratio 2022 -10,1x
Yield 2022 -
Capitalization 346 M 48,9 M 48,9 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 6
Free-Float 57,5%
Company
FluoGuide A/S is a Denmark-based biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent. The Company is a provider of solutions for maximizing surgical outcome through intelligent targeting. FluoGuide develops surgical solutions, which...
Sector :
Other Advanced Medical Equipment & Technology
Calendar :
2023-03-03 Earnings Release

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 29,33 DKK
Average target price 82,11 DKK
Spread / Average Target 180%